New Insomnia Drugs Have the Potential to Reduce the Risk of Abuse and Overdose
David Neubauer, MD, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine discusses the current landscape of insomnia trea...
5303 articles
David Neubauer, MD, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine discusses the current landscape of insomnia trea...
Mei Mei Hu, CEO of Vaxxinity, discusses the company's approach to targeting a wide variety of chronic diseases such as Alzheimer’s, Parkinson’s, mig...
Emri Seli, March of Dimes Chief Scientific Officer and Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine discuss...
Nicholas Robert, CMO of Ontada, discusses new research that examines potential factors that may impact care and outcomes for affected communities with a...
Ron Silverman, MD, Senior Vice President, Global Medical and Clinical Affairs and Chief Medical Officer at 3M discusses how the company’s AI and aut...
Michael Irizarry, Senior Vice President and Deputy Chief Clinical Officer, Alzheimer's Disease and Brain Health, at Eisai Inc.
Laura Korb Ferris, MD, PhD, Professor, University of Pittsburgh Clinical and Translational Science Institute and Director of Clinical Trials, UPMC Depar...
Ali Carbone, sister to three brothers with autism, discusses her new memoir called “What Are You Looking At?” Ali shares her firsthand perspective a...
Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show T...
Mark Stadler, CEO of AccessHope discusses cancer care and why access to the best cancer facilities is out of reach for the majority of Americans, partic...